Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hormonal therapy or chemotherapy for advanced endometrial cancer? A mixed-methods study assessing physicians' attitudes.

Archives of gynecology and obstetrics·2026
Same author

Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practice.

BMJ oncology·2026
Same author

The impact of multimodal prehabilitation on surgical outcomes in gynaecological cancer surgery.

Gynecologic oncology·2026
Same author

Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: an early health-economic evaluation in the Netherlands.

Cytotherapy·2026
Same author

Country-of-birth disparities in high-grade endometrial cancer: A European-first population-based analysis on incidence, age at presentation, and survival in an equal-access health system in the Netherlands.

European journal of cancer (Oxford, England : 1990)·2026
Same author

The impact of the patient macroenvironment on molecular subgroups in endometrial cancer.

Cancer·2026

Related Experiment Video

Updated: Dec 19, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

12.6K

Optimizing the treatment algorithm for sentinel lymph node mapping in endometrial cancer.

Johanna M A Pijnenborg1, Casper Reijnen2, Tineke F M Vergeldt1

  • 1Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands.

Seminars in Oncology
|June 10, 2020
PubMed
Summary

Sentinel lymph node (SLN) mapping improves endometrial cancer staging, but management of micro- and macrometastasis requires optimized treatment algorithms. Further research is needed to clarify adjuvant therapies for positive SLN findings.

Keywords:
Endometrial cancerMetastasisSentinel lymph nodeTreatment

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.5K
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.7K

Related Experiment Videos

Last Updated: Dec 19, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

12.6K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.5K
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.7K

Area of Science:

  • Gynecologic Oncology
  • Surgical Pathology
  • Clinical Decision-Making

Background:

  • Endometrial cancer incidence is rising due to increased life expectancy and obesity.
  • Lymph node status is critical for prognosis, but traditional lymphadenectomy offers no survival benefit and causes morbidity.
  • Sentinel lymph node (SLN) mapping is a validated alternative to full lymphadenectomy for endometrial cancer staging.

Purpose of the Study:

  • To summarize recent data on sentinel lymph node (SLN) assessment in endometrial cancer.
  • To optimize the current treatment algorithm based on SLN findings.
  • To address uncertainties regarding adjuvant treatment for varying metastasis types.

Main Methods:

  • Review and synthesis of recently published data on SLN mapping in endometrial cancer.
  • Analysis of the impact of micro- and macrometastasis on patient outcomes.
  • Evaluation of criteria for further lymphadenectomy after positive SLN detection.

Main Results:

  • Sentinel lymph node (SLN) mapping accurately identifies lymph node involvement in endometrial cancer.
  • Distinguishing between micrometastasis and macrometastasis in SLNs is crucial for treatment decisions.
  • Optimal adjuvant treatment strategies for micrometastasis and isolated tumor cells remain unclear.

Conclusions:

  • Sentinel lymph node (SLN) assessment refines staging but necessitates updated treatment guidelines.
  • Further clarification is needed on pelvic/para-aortic lymphadenectomy following positive SLN results.
  • Optimizing adjuvant therapy based on SLN findings is essential for improving endometrial cancer patient outcomes.